Leaderboards/Menopause: Health Impacts and Treatments

Menopause: Health Impacts and Treatments

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Peyton Christine Bendis
University of Wisconsin–Milwaukee
2
Kamila Ryczkowska
Medical University of Lodz
3
Sarah Glynne
The Portland Hospital
4
Felice L Gersh
University of Arizona
5
Nelsan Pourhadi
Bispebjerg Hospital
6
Madeline Wood Alexander
Sunnybrook Health Science Centre
7
Fiona Li
UNSW Sydney
8
Lynne Peeples
World Federation of Science Journalists
9
Erin R Uddenberg
Jacksonville College
10
Muqi Guo
Harvard University

Papers

1
The impact of estradiol on serotonin, glutamate, and dopamine systems
Frontiers in Neuroscience|2024
112 cit.
2
Estrogen and cardiovascular disease
Progress in Cardiovascular Diseases|2024
81 cit.
3
Menopause transition and cardiovascular disease risk
Maturitas|2024
67 cit.
4
The range and variation in serum estradiol concentration in perimenopausal and postmenopausal women treated with transdermal estradiol in a real-world setting: a cross-sectional study
Menopause The Journal of The North American Menopause Society|2024
23 cit.
5
Effect of transdermal testosterone therapy on mood and cognitive symptoms in peri- and postmenopausal women: a pilot study
Archives of Women s Mental Health|2024
19 cit.
6
Patient experience of menopause care after breast cancer in the UK: a cross-sectional study
Menopause The Journal of The North American Menopause Society|2025
12 cit.
7
Opioids and Dementia in the Danish Population
JAMA Network Open|2024
8 cit.
8
Breast cancer patients' experience of menopause care in the UK: thematic analysis of free-text comments
Menopause The Journal of The North American Menopause Society|2025
5 cit.
9
Endometrial thickness and pathology in postmenopausal women with bleeding on transdermal 17β-estradiol plus body-identical progesterone
Archives of Gynecology and Obstetrics|2025
4 cit.
10
Publication in Menopause The Journal of The North American Menopause Society (2025) [4 citations, W4414667520]
Menopause The Journal of The North American Menopause Society|2025
4 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Eija K. Laakkonen
University of Jyväskylä
2
Neil M. Schultz
Astellas Pharma (United States)
3
Mert Can Günaçtı
Haydarpaşa Numune Eğitim ve Araştırma Hastanesi
4
Genevieve Neal-Perry
University of North Carolina at Chapel Hill
5
Shuai Miao
Wuxi People's Hospital
6
Marcelo Luis Steiner
Faculdade de Medicina do ABC
7
Agata Bielecka‐Dąbrowa
Memorial Hospital
8
Neil F. Goodman
Royal Devon and Exeter Hospital
9
Weronika Adach
Medical University of Lodz
10
Mariëlle P. van Aalst
Arbo Unie

Papers

1
Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study
The Lancet|2023
244 cit.
2
Menopause and women’s cardiovascular health: is it really an obvious relationship?
Archives of Medical Science|2022
204 cit.
3
Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause
Obstetrics and Gynecology|2023
110 cit.
4
Prevalence and quality-of-life burden of vasomotor symptoms associated with menopause: A European cross-sectional survey
Maturitas|2022
70 cit.
5
Total and regional body adiposity increases during menopause—evidence from a follow‐up study
Aging Cell|2022
49 cit.
6
Menopause modulates the circulating metabolome: evidence from a prospective cohort study
European Journal of Preventive Cardiology|2022
44 cit.
7
Predictors of Long COVID in Patients without Comorbidities: Data from the Polish Long-COVID Cardiovascular (PoLoCOV-CVD) Study
Journal of Clinical Medicine|2022
43 cit.
8
Evaluation of the impact, treatment patterns, and patient and physician perceptions of vasomotor symptoms associated with menopause in Europe and the United States
Maturitas|2022
28 cit.
9
The Role of Gut Microbiota and Its Metabolites in Patients with Heart Failure
Biomedicines|2024
26 cit.
10
Extracellular vesicles and high‐density lipoproteins: Exercise and oestrogen‐responsive small RNA carriers
Journal of Extracellular Vesicles|2023
25 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Charles H. Hennekens
Florida Atlantic University
2
Karen A. Matthews
University of Pittsburgh
3
Roberta Dı́az Brinton
University of Arizona
4
Claus Christiansen
VA Eastern Colorado Health Care System
5
István Merchenthaler
University of Maryland, Baltimore
6
Nanette K. Wenger
American Heart Association
7
JoAnn E. Manson
Brigham and Women's Hospital
8
James W. Simpkins
West Virginia University
9
Richard Mayeux
Columbia University
10
Cheryl A. Frye
University at Albany, State University of New York

Papers

1
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
New England Journal of Medicine|1997
5.5k cit.
2
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
New England Journal of Medicine|2005
3.5k cit.
3
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
New England Journal of Medicine|2009
3.4k cit.
4
The use of the elevated plus maze as an assay of anxiety-related behavior in rodents
Nature Protocols|2007
3k cit.
5
Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men
Circulation|2000
2.4k cit.
6
Lack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular Disease
New England Journal of Medicine|1996
2.4k cit.
7
Comparative distribution of estrogen receptor-? and -? mRNA in the rat central nervous system
The Journal of Comparative Neurology|1997
2.3k cit.
8
Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update
Circulation|2011
2.1k cit.
9
Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular Disease
Circulation|2003
2.1k cit.
10
Estrogen plus Progestin and the Risk of Coronary Heart Disease
New England Journal of Medicine|2003
2.1k cit.

Reagents for Menopause: Health Impacts and Treatments

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 67

Lamin B2 (E1S1Q) Rabbit Monoclonal Antibody

Cited in 5 papers
#13823$161,351
View Evidence →
Cell Signaling Technology

Phospho-C/EBP alpha (Thr222/226) Antibody

Cited in 5 papers
#2844$148,362
View Evidence →
Cell Signaling TechnologyEvidence 60

MIB1 Antibody

Cited in 5 papers
#4400$317
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

PPAR gamma Regulated Fatty Acid Metabolism Antibody Sampler Kit

Cited in 8 papers
#8660$650
View Evidence →
Beckman Coulter

AMH/Mullerian-inhibiting substance ELISA kit

Cited in 6 papers
#A79765
View Evidence →
Cell Signaling TechnologyEvidence 62

Nicastrin (D65G7) Rabbit Monoclonal Antibody

Cited in 6 papers
#9447$161,351
View Evidence →